Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on April 26, 2017, to report its first-quarter financial results for the period ended March 31, 2017. The report primarily serves to furnish a press release detailing these results, which was issued on the same date. Investors should note that this 8-K filing itself does not contain the detailed financial statements or operational commentary, but rather directs them to the furnished press release (Exhibit 99.1) for that specific information. The key takeaway for investors is to review the accompanying press release for the Q1 2017 performance of Anthem, Inc. This will include important metrics such as revenue, earnings per share, membership numbers, and any forward-looking guidance or commentary on business trends. The 8-K filing confirms the release of this crucial information and serves as the official public record of its dissemination.
Key Highlights
- 1Elevance Health (then Anthem, Inc.) reported its Q1 2017 financial results on April 26, 2017.
- 2The 8-K filing is primarily an informational filing, furnishing a press release with the detailed results.
- 3The press release (Exhibit 99.1) contains the company's financial results for the quarter ended March 31, 2017.
- 4Investors are directed to the furnished press release for specific financial details and operational commentary.
- 5The filing does not include the full financial statements within the 8-K itself.
- 6Information furnished in this 8-K is generally not considered 'filed' for Section 18 purposes.